Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_assertion type Assertion NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_head.
- NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_assertion description "[SLC7A11 is identified as a direct target of miR-26b and its expression is remarkably increased in both breast cancer cell lines and clinical samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_provenance.
- NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_assertion evidence source_evidence_literature NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_provenance.
- NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_assertion SIO_000772 21510944 NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_provenance.
- NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_assertion wasDerivedFrom befree-20150227 NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_provenance.
- NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_assertion wasGeneratedBy ECO_0000203 NP876816.RAchVelxfPAAmMpVNxB-gkt1MjVxnyvgqmI7D3TzpDtcI130_provenance.